Listed

Abivax S.A.

ABVXNasdaqCIK 1956827HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Balance sheet

Cash and equivalentsEUR 516.7m, FY2025
Shareholders' equityEUR 455.2m, FY2025
Abivax S.A., balance sheet, quarterly
Line itemUnitperiod not labelled2020-12-31period not labelled2021-12-31period not labelled2022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31
Cash and equivalents$m29.3Cash and equivalents, period not labelled, at 2020-12-31EUR 29.3m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2024-04-05, accession 0001956827-24-000007.Report this figure60.7Cash and equivalents, period not labelled, at 2021-12-31EUR 60.7m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2025-03-24, accession 0001956827-25-000010.Report this figure27.0Cash and equivalents, period not labelled, at 2022-12-31EUR 26.9m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2026-03-23, accession 0001956827-26-000012.Report this figure252Cash and equivalents, FY2023, at 2023-12-31EUR 251.9m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2026-03-23, accession 0001956827-26-000012.Report this figure144Cash and equivalents, FY2024, at 2024-12-31EUR 144.2m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2026-03-23, accession 0001956827-26-000012.Report this figure517Cash and equivalents, FY2025, at 2025-12-31EUR 516.7m. XBRL concept ifrs-full:CashAndCashEquivalents. 20-F filed 2026-03-23, accession 0001956827-26-000012.Report this figure
Current assets$mnot reported75.5Current assets, period not labelled, at 2021-12-31EUR 75.5m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2024-04-05, accession 0001956827-24-000007.Report this figure36.2Current assets, period not labelled, at 2022-12-31EUR 36.2m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2025-03-24, accession 0001956827-25-000010.Report this figure286Current assets, FY2023, at 2023-12-31EUR 286.0m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2026-03-23, accession 0001956827-26-000012.Report this figure171Current assets, FY2024, at 2024-12-31EUR 170.7m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2026-03-23, accession 0001956827-26-000012.Report this figure551Current assets, FY2025, at 2025-12-31EUR 551.2m. XBRL concept ifrs-full:CurrentAssets. 20-F filed 2026-03-23, accession 0001956827-26-000012.Report this figure
Total assets$mnot reported109Total assets, period not labelled, at 2021-12-31EUR 109.2m. XBRL concept ifrs-full:Assets. 20-F filed 2024-04-05, accession 0001956827-24-000007.Report this figure75.5Total assets, period not labelled, at 2022-12-31EUR 75.5m. XBRL concept ifrs-full:Assets. 20-F filed 2025-03-24, accession 0001956827-25-000010.Report this figure327Total assets, FY2023, at 2023-12-31EUR 327.1m. XBRL concept ifrs-full:Assets. 20-F filed 2026-03-23, accession 0001956827-26-000012.Report this figure205Total assets, FY2024, at 2024-12-31EUR 205.2m. XBRL concept ifrs-full:Assets. 20-F filed 2026-03-23, accession 0001956827-26-000012.Report this figure584Total assets, FY2025, at 2025-12-31EUR 584.3m. XBRL concept ifrs-full:Assets. 20-F filed 2026-03-23, accession 0001956827-26-000012.Report this figure
Current liabilities$mnot reported32.3Current liabilities, period not labelled, at 2021-12-31EUR 32.3m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2024-04-05, accession 0001956827-24-000007.Report this figure51.5Current liabilities, period not labelled, at 2022-12-31EUR 51.5m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2025-03-24, accession 0001956827-25-000010.Report this figure90.7Current liabilities, FY2023, at 2023-12-31EUR 90.7m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2026-03-23, accession 0001956827-26-000012.Report this figure94.0Current liabilities, FY2024, at 2024-12-31EUR 94.0m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2026-03-23, accession 0001956827-26-000012.Report this figure63.0Current liabilities, FY2025, at 2025-12-31EUR 63.0m. XBRL concept ifrs-full:CurrentLiabilities. 20-F filed 2026-03-23, accession 0001956827-26-000012.Report this figure
Shareholders' equity$m1.7Shareholders' equity, period not labelled, at 2020-12-31EUR 1.7m. XBRL concept ifrs-full:Equity. 20-F filed 2024-04-05, accession 0001956827-24-000007.Report this figure25.9Shareholders' equity, period not labelled, at 2021-12-31EUR 25.9m. XBRL concept ifrs-full:Equity. 20-F filed 2025-03-24, accession 0001956827-25-000010.Report this figure7.2Shareholders' equity, period not labelled, at 2022-12-31EUR 7.2m. XBRL concept ifrs-full:Equity. 20-F filed 2026-03-23, accession 0001956827-26-000012.Report this figure196Shareholders' equity, FY2023, at 2023-12-31EUR 196.0m. XBRL concept ifrs-full:Equity. 20-F filed 2026-03-23, accession 0001956827-26-000012.Report this figure40.6Shareholders' equity, FY2024, at 2024-12-31EUR 40.6m. XBRL concept ifrs-full:Equity. 20-F filed 2026-03-23, accession 0001956827-26-000012.Report this figure455Shareholders' equity, FY2025, at 2025-12-31EUR 455.2m. XBRL concept ifrs-full:Equity. 20-F filed 2026-03-23, accession 0001956827-26-000012.Report this figure

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. Listed shows no prices and gives no investment advice.